EQT Fund Management S.a r.l. 13F holdings
EQT Fund Management S.a r.l. reported 5 positions with a total reported value of $862.6M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-13. Top holdings by reported value: WAY WAYSTAR HLDG CORP (59.2%), PHVS PHARVARIS N V (13.7%), OCS OCULIS HOLDING AG (11.2%), EVMN EVOMMUNE INC (8.1%), AGMB AGOMAB THERAPEUTICS NV (7.7%). Against 2026-03-31 it opened 0 new positions and exited 0. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when EQT Fund Management S.a r.l. files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
5 largest of 5 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| WAY WAYSTAR HLDG CORP | 24,879,437 | $510.8M | 59.2% |
| PHVS PHARVARIS N V | 3,424,609 | $118.4M | 13.7% |
| OCS OCULIS HOLDING AG | 6,950,294 | $96.4M | 11.2% |
| EVMN EVOMMUNE INC | 5,288,313 | $70.3M | 8.1% |
| AGMB AGOMAB THERAPEUTICS NV | 5,141,992 | $66.7M | 7.7% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 0 in all · reported value as of 2026-06-30
No new positions.
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 0 in all · reported value as of 2026-03-31
No positions were sold out.
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| OCS OCULIS HOLDING AG | 5,900,294 | 6,950,294 | +17.8% | $96.4M |
| EVMN EVOMMUNE INC | 4,929,633 | 5,288,313 | +7.3% | $70.3M |
Decreases
No position was decreased.
CIK 1834239 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
